Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Vera Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +9 vs. Q2 2021
- Shares held
- 14.7M
- +197.4K (+1.4%) vs. Q2 2021
- Total value
- $252.4M
- +$66.3M (+35.6%) vs. Q2 2021
- New holders
- 16
- 7 more added
- Sold out
- 7
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 47 | $1.00K | 0.00% | +19+67.9% | Added |
| Ameritas Investment Partners, Inc. | 542 | $9.00K | 0.00% | +542 | New |
| Tower Research Capital LLC (TRC) | 605 | $10.0K | 0.00% | +605 | New |
| Legal & General Group Plc | 662 | $12.0K | 0.00% | +662 | New |
| Royal Bank of Canada | 780 | $13.0K | 0.00% | +780 | New |
| Citigroup Inc | 810 | $14.0K | 0.00% | +810 | New |
| New York State Common Retirement Fund | 1,200 | $21.0K | 0.00% | +1,200 | New |
| STRS Ohio | 1,600 | $27.0K | 0.00% | +1,600 | New |
| California State Teachers Retirement System | 3,817 | $66.0K | 0.00% | +3,817 | New |
| American International Group, Inc. | 3,867 | $67.0K | 0.00% | +3,867 | New |
| Deutsche Bank AG | 4,068 | $71.0K | 0.00% | +4,068 | New |
| Bank of America Corp | 6,521 | $113.0K | 0.00% | +309+5.0% | Added |
| Bank of New York Mellon Corp | 13,224 | $230.0K | 0.00% | +13,224 | New |
| Charles Schwab Investment Management Inc | 16,948 | $295.0K | 0.00% | +16,948 | New |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $309.0K | 0.00% | 00.0% | Unchanged |
| Gyon Technologies Capital Management, LP | 19,042 | $330.0K | 0.09% | +19,042 | New |
| Morgan Stanley | 22,006 | $382.0K | 0.00% | +20,222+1,133.5% | Added |
| Parkman Healthcare Partners LLC | 25,638 | $445.0K | 0.11% | −50,000−66.1% | Reduced |
| Northern Trust Corp | 59,315 | $1.03M | 0.00% | +59,315 | New |
| Geode Capital Management, LLC | 71,608 | $1.24M | 0.00% | +55,532+345.4% | Added |
| State Street Corp | 75,255 | $1.31M | 0.00% | +75,255 | New |
| JPMorgan Chase & Co | 78,652 | $1.36M | 0.00% | +78,652 | New |
| Vanguard Group Inc | 245,835 | $4.26M | 0.00% | +193,567+370.3% | Added |
| BlackRock Inc. | 314,037 | $5.45M | 0.00% | +313,444+52,857.3% | Added |
| Octagon Capital Advisors LP | 696,126 | $12.1M | 2.97% | −436,545−38.5% | Reduced |
| Alphabet Inc. | 944,791 | $16.4M | 0.39% | 00.0% | Unchanged |
| KPCB XVI Associates, LLC | 1,343,152 | $23.3M | 10.38% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,728,348 | $29.1M | 0.03% | −10,345−0.6% | Reduced |
| Sofinnova Investments, Inc. | 2,914,776 | $50.6M | 3.24% | 00.0% | Unchanged |
| Abingworth LLP | 2,960,231 | $51.4M | 11.66% | 00.0% | Unchanged |
| FMR LLC | 3,139,402 | $52.6M | 0.00% | +16,890+0.5% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −81,452−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −46,069−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,841−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,747−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −956−100.0% | Sold out |